Evidence map›Paper›PMID 39726700›Full record

ArticleFrontiers in oncology2024

Association of

Gulmira Kulmambetova, Botakoz Kurentay, Alua Gusmaulemova, Talgat Utupov, Dana Auganova, Pavel Tarlykov, Meiram Mamlin, Saule Khamzina, Sanzhar Shalekenov, Arman Kozhakhmetov

Abstract read
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Quantification of EctopicInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Comparative insights intoFrontiers in microbiology · 2025
    Review
  7. Investigation of the relationship betweenFrontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gulmira KulmambetovaDepartment of Genomics, National Center for Biotechnology, Astana, Kazakhstan.
Botakoz KurentayDepartment of Genomics, National Center for Biotechnology, Astana, Kazakhstan.
Alua GusmaulemovaDepartment of Genomics, National Center for Biotechnology, Astana, Kazakhstan.
Talgat UtupovDepartment of Genomics, National Center for Biotechnology, Astana, Kazakhstan.
Dana AuganovaDepartment of Genomics, National Center for Biotechnology, Astana, Kazakhstan.
Pavel TarlykovDepartment of Genomics, National Center for Biotechnology, Astana, Kazakhstan.
Meiram MamlinMultidisciplinary Surgery Center, National Research Oncology Center, Astana, Kazakhstan.
Saule KhamzinaMultidisciplinary Surgery Center, National Research Oncology Center, Astana, Kazakhstan.
Sanzhar ShalekenovMultidisciplinary Surgery Center, National Research Oncology Center, Astana, Kazakhstan.
Arman KozhakhmetovDepartment of Surgery, Nazarbayev University School of Medicine, Astana, Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Methods: A total of 249 biopsy samples of tumor and paired normal tissues were collected from patients with CRC. Biopsy samples were screened for detection of Results: The frequencies of detection of Conclusions: Our results showed an association between the presence of

Indexed as

abundancecolorectal cancerFusobacterium nucleatumKazakhstanqPCR

Identifiers

PMID39726700
PMCPMC11669545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.